Fingerprint
Dive into the research topics of 'Synergistic effect between erlotinib and MEK inhibitors in KRAS wild-type human pancreatic cancer cells'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Caroline H. Diep, Ruben M. Munoz, Ashish Choudhary, Daniel D. Von Hoff, Haiyong Han
Research output: Contribution to journal › Article › peer-review